Trial Profile
Phase II study of alternate-day treatment with S-1 as adjuvant chemotherapy for patients with lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Lung cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Mar 2019 Status changed from recruiting to completed.
- 12 Aug 2013 New trial record